Objective: The concurrent presence of multiple chronic diseases, termed multimorbidity, is increasingly prevalent among patients with chronic illnesses. This phenomenon is particularly pronounced in middle-aged women, yet has not received adequate attention. The objective of this study was to investigate the pattern of multimorbidity and its changes over time in perimenopausal women.
Methods: A longitudinal study was conducted on the coexistence of chronic diseases in 3990 middle-aged women aged 40-65 years. The primary analytical tools were association rule mining and cross-lagged panel modeling, applied to the comprehensive medical examination data of the cohort.
Result: At the first medical examination, 77.72% of participants were diagnosed with two or more chronic diseases, a figure that rose to 86.98% by the last examination. The most frequently observed multimorbidity combination pair under strong association rules is obesity and dyslipidemia. Additionally, the findings indicated that central obesity significantly influences lipid composition.
Conclusion: This study highlights the elevated prevalence of multimorbidity in perimenopausal women and the added complexity of endocrine-related disorders at this life stage. There is an urgent need to develop personalized health management strategies for this demographic and to monitor and intervene in their health status in order to achieve healthy aging for perimenopausal women.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/13697137.2025.2470449 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Plasma Cell-Rich Lymphoid Neoplasm in an Endocervical Polyp of the Uterine Cervix in a Perimenopausal 52-Year-Old Woman.
HCA Healthc J Med
February 2025
St David's North Austin Medical Center, Austin, Texas.
Background: The adaptive immune system consists of T and B lymphocytes, with some B lymphocytes further differentiating into plasma cells that secrete antibodies and make up the humoral immune system. Extramedullary plasmacytoma, mucosa-associated lymphoid tissue (MALT) lymphoma, and plasmablastic lymphoma are all plasma cell-rich lymphoid neoplasms that rarely present in the female genital tract. To date, few case reports of these malignancies arising within the uterine cervix exist.
View Article and Find Full Text PDFTrophoblastic tumor in perimenopausal women: A case report and literature review.
Int J Surg Case Rep
March 2025
Department of Gynecology and Obstetrics, CHU Fattoma Bourguiba, University of Monastir, Tunisia.
Background And Importance: Placental site trophoblastic tumor (PSTT) a rare form of gestational trophoblastic disease, originates from intermediate trophoblastic cells and presents with nonspecific symptoms, complicating diagnosis. PSTT primarily affects women of childbearing age, but occurrences in perimenopausal women are exceptionally rare.
Case Presentation: We report a case of a 54-year-old perimenopausal woman presenting with a two-month history of abnormal uterine bleeding.
Neurophysiological correlates of subjective cognitive decline in perimenopausal and postmenopausal midlife women at risk for Alzheimer's disease.
Menopause
March 2025
Department of Radiology, Weill Cornell Medicine, New York, NY.
Objective: This study aimed to investigate neurophysiological correlates of subjective cognitive decline (SCD) among midlife women at risk for Alzheimer's disease (AD).
Methods: We examined 156 cognitively normal perimenopausal and postmenopausal women aged 40 to 65 years, with an AD family history and/or apolipoprotein E epsilon 4 genotype, who were not on menopause hormone therapy. Participants underwent neuropsychological testing, health and menopausal symptom questionnaires, and brain volumetric magnetic resonance imaging, arterial spin labeling-magnetic resonance (MR) measuring cerebral blood flow, and 31phosphorus magnetic resonance spectroscopy (31P-MRS) measuring mitochondria high-energy phosphates (adenosine triphosphate [ATP], phosphocreatine [PCr], inorganic phosphate [Pi]).
Premenopausal and perimenopausal predictors of postmenopausal health and well-being: Testing a disposition-belief-motivation framework.
Appl Psychol Health Well Being
May 2025
Department of Psychology, Wayne State University, Detroit, MI, USA.
The present study tested a Disposition-Belief-Motivation model of peri- and post-menopausal health and well-being using a 20-year prospective design from the Midlife in the United States (MIDUS) study. Screening algorithms based on World Health Organization guidelines produced a sample of women that was premenopausal at Time 1, perimenopausal at Time 2, and postmenopausal at Time 3 (N = 247). Prospective path modeling tested the direct and indirect effects of premenopausal factors on peri- and post-menopausal health and well-being.
View Article and Find Full Text PDFLong-term clinical outcomes of dienogest for perimenopausal women with symptomatic adenomyosis.
Sci Rep
March 2025
Department of Obstetrics and Gynecology, National Taiwan University College of Medicine and Hospital, No. 8, Zhongshan S. Rd., Zhongzheng Dist, 100225, Taipei City, Taiwan (R.O.C.).
We aimed to evaluate the successful long-term use of dienogest for the management of pelvic pain and bleeding control in perimenopausal women with symptomatic adenomyosis using real-world data. All women aged ≥ 40 years with adenomyosis who complained of dysmenorrhea and/or menorrhagia and received dienogest between September 2018 and December 2021 were retrospectively recruited. The primary outcome was successful long-term use of dienogest for pelvic pain and/or bleeding control.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!